Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EpiATLAS - a reference for human epigenomic research.

bioRxiv : the preprint server for biology·2026
Same author

The Growth Supporting Role of ZDHHC11 Is Linked to the MEF2B-BCL6 Regulatory Circuit in Burkitt Lymphoma.

International journal of cancer·2026
Same author

Relevance of Epstein-Barr Virus (EBV) miRNAs in EBV-Infected B Cells and B-Cell Lymphomas.

Cancers·2026
Same author

Enhancing Antibacterial Dental Matrices: Balancing Antibacterial Activity and Mechanical Properties Through Quaternary Ammonium UDMA Analogues.

Polymers·2026
Same author

Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients.

British journal of haematology·2025
Same author

Mutational landscape and risk estimates of DDR genes in Chinese ovarian cancer patients.

Journal of ovarian research·2025

Related Experiment Video

Updated: May 15, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Studying microRNAs in lymphoma.

Joost Kluiver1, Izabella Slezak-Prochazka, Anke van den Berg

  • 1Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. j.l.kluiver@umcg.nl

Methods in Molecular Biology (Clifton, N.J.)
|January 9, 2013
PubMed
Summary

This study details methods for investigating microRNAs (miRNAs) in lymphoma. Researchers can now assess miRNA expression, overexpress miRNAs, and determine their oncogenic or tumor-suppressive roles in lymphomagenesis.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

Related Experiment Videos

Last Updated: May 15, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of cellular processes, including development and differentiation.
  • Dysregulation of miRNAs is implicated in various diseases, notably lymphoma.
  • Understanding miRNA functions is vital for advancing lymphoma research and treatment.

Purpose of the Study:

  • To describe robust methodologies for studying microRNA involvement in lymphoma.
  • To provide protocols for quantitative assessment and functional analysis of miRNAs in lymphomagenesis.
  • To facilitate the investigation of specific miRNAs as potential therapeutic targets or biomarkers in lymphoma.

Main Methods:

  • Multiplex reverse transcription (RT) followed by quantitative polymerase chain reaction (qPCR) for differential miRNA expression analysis.
  • Lentiviral-based ectopic expression systems for stable miRNA overexpression in lymphoma cells.
  • A functional assay to ascertain whether a candidate miRNA acts as an oncogene or a tumor suppressor in lymphomagenesis.

Main Results:

  • Established protocols enable precise quantification of candidate miRNA expression levels.
  • Successfully demonstrated stable overexpression of miRNAs using lentiviral vectors.
  • Developed a method to functionally characterize miRNAs as oncogenes or tumor suppressors in the context of lymphoma.

Conclusions:

  • The described methods provide a comprehensive toolkit for exploring the role of miRNAs in lymphoma.
  • These techniques will aid in identifying novel miRNA biomarkers and therapeutic strategies for lymphoma.
  • This work empowers researchers to elucidate the specific functions of miRNAs in lymphomagenesis.